The withdrawal of phenolic tablets and phenolic tablets involved 81 approval numbers, more than 60 enterprises

The list of phenolic tablets and phenolic tablets published simultaneously by the State Drug Administration includes 71 phenolic tablet approval numbers and 10 phenolic tablet approval numbers, involving more than 60 production enterprises such as Tianjin Lisheng Pharmaceutical Co., Ltd., Ha Pharmaceutical Group Sansimi Pharmaceutical Four Factory Co., Ltd., Yuanda Pharmaceutical (China) Co., Ltd., Henan Shuanghe Huali Pharmaceutical Co., Ltd. and Zhengda Tianqing Pharmaceutical Group Co., Ltd.
" phenolic tablets and phenolic tablets have long been not clinically commonly used drugs, its alternative drugs of many types, adequate supply.
Lianmei, vice chairman of the Pharmaceutical Services Innovation Committee of the Chinese Pharmacists Association, said that with advances in pharmaceutical technology and product iterations, it is normal for drugs with low risk of benefit to be eliminated.
phenol tablets and phenolic tablets, commonly known as "fruit guide tablets", are often used to treat habitual stubborn constipation.
, as laxatives, phenolic tablets and phenolic tablets in the short term quickly but highly irritating, is a non-clinical commonly used drug, and there are better alternative drugs.
", formal large medical institutions basically do not use phenolic tablets and phenolic tablets.
," she added.
Lianmei told reporters that phenolic tablets and phenolic tablets containing more clinical alternative drugs, only in the rapid effect of laxatives, there are more than sassacy intestinal tablets and kaiserus and other alternative drugs.
She also stressed that such irritating laxatives are limited to short-term use, and should be standardized, not long-term use, constipation problems should first through diet, exercise, sleep and other lifestyle adjustments to seek improvement of the problem, if necessary, to seek medical professionals, not recommended blind medication.
recent years, the State Drug Administration combed the drug registration certificate, strengthen the quality supervision of drugs, Yan Lianmei clearly felt that the risk of benefits is not high and long-term non-production of drugs are being accelerated clean-up.
said the industry should look at the cancellation of certificates for drugs.
" drugs are constantly being updated and iterative, and when safer, more effective, and better alternatives appear on the market, or when a drug has a serious adverse reaction to its use, it may be withdrawn.
" (Reporter Lu Nan)